Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Tumor mutation burden (TMB) and VHL mutation play a crucial role in the management of patients with clear cell renal cell carcinoma (ccRCC), such as guiding adjuvant chemotherapy and improving clinical outcomes. However, the time-consuming and expensive high-throughput sequencing methods severely limit their clinical applicability. Predicting intratumoral heterogeneity poses significan...
Breast cancer is a prevalent malignancy affecting women worldwide. Currently, there are no precise molecular biomarkers with immense potential for accurately predicting breast cancer development, which limits clinical management options. Recent evidence has highlighted the importance of metastatic and tumor-infiltrating immune cells in modulating the antitumor therapy response. However, the progno...
Background Artificial intelligence (AI) systems can be used to identify interval breast cancers, although the localizations are not always accurate. P...
PURPOSE: Palliative care is recommended for patients with cancer with a life expectancy of <12 months. Machine learning (ML) techniques can help in pr...
BACKGROUND: Homologous recombination plays a vital role in the occurrence and drug resistance of gastric cancer. This study aimed to screen new gastri...
OBJECTIVE: Breast cancer is one of the leading cancer causes among women worldwide. It can be classified as invasive ductal carcinoma (IDC) or metasta...
PURPOSE: Most research on artificial intelligence-based auto-contouring as template (AI-assisted contouring) for organs-at-risk (OARs) stem from high-...
BACKGROUND: Lung cancer is one of the most common types of cancer in the United Kingdom. It is often diagnosed late. The 5-year survival rate for lung...
OBJECTIVE: If excellent response (ER) occurs after radioactive iodine (RAI) treatment in patients with differentiated thyroid carcinoma (DTC), the rec...
The treatment of primary central nervous system tumors is challenging due to the blood-brain barrier and complex mutational profiles, which is associa...
Most complex diseases, including cancer and non-malignant diseases like asthma, have distinct molecular subtypes that require distinct clinical appr...
Polygenic risk scores (PRSs) can significantly enhance breast cancer risk prediction when combined with clinical risk factor data. While many studie...
With the continuous advancement of artificial intelligence in the field of prostate cancer research, numerous studies have shown that AI performance c...
OBJECTIVE: To explore the diagnostic value of micropure imaging (MI) combined with strain elastography (SE) in correcting artificial intelligence (AI)...
Researching the specificity of TCR contributes to the development of immunotherapy and provides new opportunities and strategies for personalized ca...
This study aims to develop and validate a machine learning (ML) predictive model for assessing mortality in patients with malignant tumors and hyperka...
Recent advances in molecular and genetic research have identified a diverse range of brain tumor sub-types, shedding light on differences in their m...
With the ever-increasing number of artificial intelligence (AI) systems, mitigating risks associated with their use has become one of the most urgent ...
The T cell receptor (TCR) repertoire is pivotal to the human immune system, and understanding its nuances can significantly enhance our ability to for...
Cell-cell communications is crucial for the regulation of cellular life and the establishment of cellular relationships. Most approaches of inferring ...